NCT02539849View on ClinicalTrials.gov

Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 19, 2017

Study Completion Date

December 19, 2017

Conditions
Crohn Disease
Interventions
DIETARY_SUPPLEMENT

FOS

DRUG

Adalimumab

Trial Locations (5)

15706

Hospital de Santiago, Santiago de Compostela

17007

Hospital Josep Trueta, Girona

28006

Hospital La Princesa, Madrid

08907

Hospital de Bellvitge, Hospitalet Del Llobregat

08035

Hospital Universitari vall d'Hebron, Barcelona

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER